AzTrials
AzTrials

DENT IMPLANTSPhase 2NCT07800949

Clinical and Radiographic Evaluation of Using Regular Versus Narrow Diameter Dental Implantto Support Mandibular Complete Over Denture

A Phase 2 study testing Implant in people with DENT IMPLANTS, run by Mostafa Bahaa at 1 site in Egypt.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

After teeth extraction and over years of removable denture wearing, atrophy of residual alveolar ridges progresses. The lower complete denture is the most problem issue in oral cavity due to bone loss and presence of the tongue, which is the most movable part in the oral cavity, this condition resulting in a lack of… Read more about this study

Who is it for?
Ages 55 to 65 years
Conditions the study is for
DENT IMPLANTS
What is being tested?
Implant
Could I receive a placebo?
No, everyone receives an active treatment
How many people
12 participants
Where
1 siteEgypt
Study dates
25 Aug 2026to 30 Oct 2027
Phase
Phase 2
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 55 to 65 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • . All patients should be free from any systemic diseases that might affect the bone quality or post-operative healing.
  • Completely edentulous patients with their age range from 55 to 65 years
  • All patients have Angle's Class I maxillomandibular relationship
  • Normal facial symmetry with no signs and symptoms of temporomandibular disorders.
  • Cooperative patients
  • Adequate inter-arch space.
Show all 11Show fewer
  • All patients have recent and old extractions ,a period of at least 6 months from the date of last extraction.
  • All patients have lower arch with irregular buccolingual thickness .
  • Edentulous ridge covered by healthy firm mucoperiosteum, without abnormal morphology.
  • Normal tongue size.
  • All the selected patients should be free from any oral pathological lesions such as cysts, remaining root, or residual infection.

Who cannot join

  • General health conditions preclude a minor surgical intervention, risk patients are excluded.
  • Local anesthesia with a vasoconstrictor is contraindicated
  • Immunosuppressive therapy, prolonged intake of antibiotics or corticosteroids, or brittle metabolic disease history.

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Egypt1 site, 1 recruiting
  • Al-Azhar University

    Cairo

    Basma Mahrous, PhD, 01067009096, manal.hamouda@phrm.menoufia.edu.eg

    Recruiting

Other trials in Egypt

About this study

After teeth extraction and over years of removable denture wearing, atrophy of residual alveolar ridges progresses. The lower complete denture is the most problem issue in oral cavity due to bone loss and presence of the tongue, which is the most movable part in the oral cavity, this condition resulting in a lack of retention, stability, and support of the dentures, which directly affect the patient's confidence, function, comfort and bring a major challenge for prosthodontics

Conditions
DENT IMPLANTS
Being tested
Implant

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • ImplantOther

    Two (regular and narrow) dental implants will be placed in the canine region of the edentulous mandible according to surgical protocols, its 7 accurate position will be determined as relates to the vital structures by the cone beam radiograph.

Study groups in NCT07800949
Study groupRoleWhat they receive
Treatment armOther12 edentulous patients have mandibular ridges and have Angle's Class I maxillomandibular relationship
Receives: Other: Implant

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Radiographical evaluation

    measuring the crestal bone height around implant by cone beam computed tomography (CBCT).

    Measured: 3 months

  2. Radiographically

    measuring the crestal bone density around implant by cone beam computed tomography (CBCT).

    Measured: 3 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted2 Sep 2026
  2. Study start25 Aug 2026
  3. Primary completion25 Aug 2027 (estimated)
  4. Study completion30 Oct 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 2
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
12 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07800949
Sponsor's protocol ID
54789
Status last verified
Sep 2026
First submitted
16 Aug 2026
Last updated
2 Oct 2026
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A Phase 2 study testing Implant in people with DENT IMPLANTS, run by Mostafa Bahaa at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 11 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 2 Oct 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this phase mean?

Phase 2 studies give the treatment to a larger group to see whether it has the intended effect and to keep checking safety.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Each site lists its own contact: choose the nearest one under Trial locations. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Radiographical evaluation (time frame: 3 months). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 2 Oct 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in